J Andrew Doyle

Dr. J Andrew Doyle

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Journal of School Health
Verified
Journal Article
Closed access
PDF file
JSJames A. Stewart
James A. Stewart
DDDavid A. Dennison
David A. Dennison
HKHarold W. Kohl
Harold W. Kohl
JDJ Andrew Doyle
J Andrew Doyle

JKJennifer A. Kurtz
Jennifer A. Kurtz
TVTrisha VanDusseldorp
Trisha VanDusseldorp
JDJ Andrew Doyle
J Andrew Doyle
JOJeffrey Scott Otis
Jeffrey Scott Otis
Taurine has become a popular supplement among athletes attempting to improve performance. While the effectiveness of taurine as an ergogenic aid remains controversial, this paper summarizes the current evidence regarding the efficacy of taurine in aerobic and anaerobic performance, metabolic stress, muscle soreness, and recovery. Google Scholar, Web of Science, and MedLine (PubMed) searches were conducted through September 2020. Peer-reviewed studies that investigated taurine as a single ingredient at dosages of < 1 g - 6 g, ranging from 10 to 15 min-to-2 h prior to exercise bout or chronic dose (7 days- 8 weeks) of consumption were included. Articles were excluded if taurine was not the primary or only ingredient in a supplement or food source, not published in peer-reviewed journals, if participants were older than 50 years, articles published before 1999, animal studies, or included participants with health issues. A total of 19 studies met the inclusion criteria for the review. Key results include improvements in the following: VO2max, time to exhaustion (TTE; n = 5 articles), 3 or 4 km time-trial (n = 2 articles), anaerobic performance (n = 7 articles), muscle damage (n = 3 articles), peak power (n = 2 articles), recovery (n = 1 article). Taurine also caused a change in metabolites: decrease in lactate, creatine kinase, phosphorus, inflammatory markers, and improved glycolytic/fat oxidation markers (n = 5 articles). Taurine dosing appears to be effective at ~ 1–3 g/day acutely across a span of 6–15 days (1–3 h before an activity) which may improve aerobic performance (TTE), anaerobic performance (strength, power), recovery (DOMS), and a decrease in metabolic markers (creatine kinase, lactate, inorganic phosphate). Limited and varied findings prohibit definitive conclusions regarding the efficacy of taurine on aerobic and anaerobic performance and metabolic outcomes. There are mixed findings for the effect of taurine consumption on improving recovery from training bouts and/or mitigating muscle damage. The timing of taurine ingestion as well as the type of exercise protocol performed may contribute to the effectiveness of taurine as an ergogenic aid. More investigations are needed to better understand the potential effects of taurine supplementation on aerobic and anaerobic performance, muscle damage, metabolic stress, and recovery.

1 September 1998 in Research Quarterly for Exercise and Sport
Verified
Journal Article
Closed access
JDJ Andrew Doyle
J Andrew Doyle
AMAnita L. Martinez
Anita L. Martinez

17 May 2024 in South African Journal of Botany
Verified
Journal Article
Closed access
SESiobhan M. Eze
Siobhan M. Eze
CMChishimba N. Mowa
Chishimba N. Mowa
DWDesiree Wanders
Desiree Wanders
JDJ Andrew Doyle
J Andrew Doyle
BWBrett Wong
Brett Wong
JOJeffrey Scott Otis
Jeffrey Scott Otis

9 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JKJennifer Kurtz
Jennifer Kurtz
Rafaela FeresinRafaela Feresin
Rafaela Feresin
JGJacob Grazer
Jacob Grazer
JOJeffrey Scott Otis
Jeffrey Scott Otis
KWKathryn E. Wilson
Kathryn E. Wilson
KZKevin Zwetsloot
Kevin Zwetsloot
Background: Quercetin (QCT) and citrulline (CIT) have been independently associated with improved antioxidant capacity and nitric oxide (NO) production, potentially enhancing cardiovascular function and exercise performance. This study aimed to evaluate the combined and independent effects of QCT and CIT supplementation on NO metabolites and antioxidant biomarkers in 50 trained cyclists undergoing a 20 km cycling time trial (TT). Methods: In a randomized, double-blind, placebo-controlled design, forty-two male and eight female trained cyclists were assigned to QCT + CIT, QCT, CIT, or placebo (PL) groups. Supplements were consumed twice daily for 28 days. Biochemical assessments included NO metabolites (nitrate/nitrite), ferric reducing antioxidant power (FRAP), superoxide dismutase (SOD) activity, and antioxidant capacity, measured pre- and post-TT. Results: NO metabolites were significantly elevated post-supplementation (p = 0.03); however, no significant interaction effects were observed for NO metabolites, FRAP, SOD, or antioxidant capacity across the groups (p > 0.05). Post-hoc analyses revealed that QCT significantly reduced FRAP concentrations compared to PL (p = 0.01), while no significant changes in SOD or antioxidant capacity were found across any groups. Conclusions: These findings suggest that combined and independent QCT and CIT supplementation did not significantly improve these biomarkers, suggesting that baseline training adaptations, supplementation timing, and individual variability may influence the efficacy of these compounds in enhancing exercise performance and oxidative stress markers. The ergogenic efficacy of QCT + CIT on antioxidant-related markers remains inconclusive.

1 May 2007 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
JDJ Andrew Doyle
J Andrew Doyle
MGMichael S. Green
Michael S. Green
BCBenjamin T. Corona
Benjamin T. Corona
JSJoseph Simone
Joseph Simone
DDDavid A. Dennison
David A. Dennison